LWM
LGND icon

Liberty Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History

Liberty Wealth Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11
Closed -$1K – 692
2021
Q3 		$1K Hold
11
– – ﹤0.01% 1124
2021
Q2 		$1K Hold
11
– – ﹤0.01% 1008
2021
Q1 		$1K Hold
11
– – ﹤0.01% 881
2020
Q4 		$1K Hold
11
– – ﹤0.01% 880
2020
Q3 		$1K Hold
11
– – ﹤0.01% 815
2020
Q2 		$1K Hold
11
– – ﹤0.01% 797
2020
Q1 		$1K Hold
11
– – ﹤0.01% 815
2019
Q4 		$1K Hold
11
– – ﹤0.01% 840
2019
Q3 		$1K Hold
11
– – ﹤0.01% 803
2019
Q2 		$1K Hold
11
– – ﹤0.01% 833
2019
Q1 		$0 Buy
+11
New +$833 ﹤0.01% 794

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Liberty Wealth Management's LGND Position: Q4 2021 in Review

Liberty Wealth Management sold out of Ligand Pharmaceuticals (LGND) in Q4 2021, closing a stake of 11 shares — an estimated $1K sold.

Liberty Wealth Management first reported a position in LGND in Q1 2019 and held it in 11 quarters. The position peaked at $1K in Q3 2021. 221 funds tracked by Wall St. Rank hold LGND as of Q4 2021.

  • Liberty Wealth Management reported no remaining Ligand Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 11 Ligand Pharmaceuticals shares in Q4 2021, an estimated $1K.
  • Liberty Wealth Management first reported a position in Ligand Pharmaceuticals in Q1 2019 and held it in 11 quarters.
  • Liberty Wealth Management's Ligand Pharmaceuticals position peaked at $1K in Q3 2021.
  • 221 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.